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The pulmonary vasculature: 
Achilles heel of the 
Fontan circulation
The Authors’ reply:
We thank Yalta and colleagues1 for their 
comments concerning our article reporting 
the relation between pulmonary artery size 
and functional capacity in patients with a 
Fontan circulation, recently published in this 
Journal.2 The emerging paradigm in Fontan 
physiology considers the pulmonary vascu-
lature a key determinant of cardiac output.3 
In the absence of obstructions in the cavo- 
pulmonary connection, both proximal 
pulmonary arteries and pulmonary vascular 
bed, in the absence of a subpulmonary pump, 
may represent a bottleneck limiting transpul-
monary flow, and thus preload of the single 
ventricle and ultimately cardiac output.
In normal physiology, pulmonary vascular 
resistance is predominantly determined by 
the pulmonary vascular bed, whereas pulsa-
tile load formed by the proximal elastic 
conduit arteries is minimal. However, 
in the Fontan circulation, the proximal 
elastic pulmonary arteries may significantly 
contribute to the total pulmonary resis-
tance due to hypoplasia as a consequence 
of reduced flow conditions and abnormal 
growth, both prenatally and postnatally, but 
also because of the development of increased 
impedance under abnormal chronic non- 
pulsatile low- pressure flow from the initi-
ation of the Fontan circulation with the 
instalment of the Glenn- anastomose. Finally, 
pulmonary artery distortions due to surgical 
interventions may constitute extra resis-
tances within the pulmonary vasculature.
The single ventricle undergoes a transition 
from overloading to underloading (relative 
to ventricular size for body surface area) 
between initial palliation and the comple-
tion of the Fontan circulation. After Fontan 
completion, it is difficult to normalise 
preload for the ‘oversized’ single ventricle 
due to the chronic abnormal pulmonary 
flow conditions. Potential options to correct 
this reduced preload include increasing 
pulmonary blood flow by aortopulmonary 
connections, either natural or surgical, or 
bypassing the pulmonary circulation by 
means of a fenestration. Also, decreasing the 
impedance and resistance of the pulmonary 
circulation as well as increasing ventricular 
suction by improving lusitropy by pharma-
cological interventions has been suggested.3
Yalta and colleagues correctly bring up 
that subclinical systemic ventricular dysfunc-
tion may play a role in a reduced clinical 
functional status in patients with a Fontan 
circulation. Adequate diastolic ventricular 
function is crucial for a well- functioning 
Fontan circulation by means of main-
taining low ventricular filling pressures (to 
increase transpulmonary gradient), but can 
decline over time due to chronically reduced 
preload which may lead to a vicious circle of 
deterioration of diastolic function. Presump-
tive evidence both through histology and 
clinical imaging has emerged that myocar-
dial fibrosis associated with chronic low 
preload, and thus too low diastolic stretch 
of myocytes, contributes to this late diastolic 
dysfunction. Systolic ventricular dysfunc-
tion, although this may occur in patients 
with a Fontan circulation, is not a character-
istic feature of the failing Fontan.
Yalta et al suggest that ventricular volume 
overload due to aortopulmonary collaterals 
may lead to systolic ventricular dysfunction. 
Although they are correct that such collat-
eral flow could conceivably lead to ventric-
ular overload, but since single ventricles are 
usually larger than normal systemic ventri-
cles, this seems only likely when this flow is 
excessively large. Ample and ongoing debate 
exists whether aortopulmonary collaterals in 
the Fontan circulation will have beneficial or 
unfavourable effects.
In our cohort, we found Nakata index 
to correlate positively with cardiac index 
(r=0.418, p=0.009), end- diastolic volume 
(r=0.413, p=0.010) and stroke volume 
(r=0.399, p=0.013). This supports the 
association between pulmonary artery size, 
ventricular loading and ventricular efficiency. 
This is in line with the current paradigm that 
considers the pulmonary vasculature a key 
factor determining ventricular preload, and 
thus in the longer term, ventricular diastolic 
function and functional capacity.
In conclusion, the pulmonary vascu-
lature is of paramount importance for 
a well- functioning Fontan circulation. 
Treatment strategies should be aimed at 
optimising and balancing initial pulmo-
nary flow and growth, starting already 
before instalment of the Fontan circula-
tion. In addition, the potential positive 
effects of (partial) pulsatile pulmonary 
flow (natively or mechanically) should 
be (re- )considered. During follow- up, 
proximal pulmonary artery flow–
limiting lesions should be monitored 
and intervened on. Molecular mecha-
nisms involved in peripheral pulmonary 
vascular remodelling should be studied 
to identify new pharmaceutical treat-
ment targets.
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